Evidence map›Paper›PMID 38600569›Full record

ArticleJournal of neuroinflammation2024

Fascin-1 limits myosin activity in microglia to control mechanical characterization of the injured spinal cord.

Jinxin Huang, Xuyang Hu, Zeqiang Chen, Fangru Ouyang, Jianjian Li, Yixue Hu, Yuanzhe Zhao, Jingwen Wang, Fei Yao, Juehua Jing and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Jinxin Huang *Department of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Xuyang Hu *Department of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Zeqiang ChenDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Fangru OuyangDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Jianjian LiDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Yixue HuDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Yuanzhe ZhaoDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Jingwen WangDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Fei YaoDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China. feiyao@ustc.edu.cn.
Juehua JingDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China. jjhhu@sina.com.
Li ChengDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China. chengli7788@163.com.
Anhui Medical University · CN

Funding

Anhui Provincial Clinical Research Transformation Project 202304295107020009Anhui Provincial Clinical Research Transformation Project 202304295107020013Anhui Provincial Natural Science Foundation Project 2208085MH222Anhui Provincial Natural Science Research Key Project KJ2021A0310National Natural Science Foundation of China 82271413
6 · The paper itself

Abstract

backgroundMechanical softening of the glial scar region regulates axonal regeneration to impede neurological recovery in central nervous system (CNS) injury. Microglia, a crucial cellular component of the glial scar, facilitate neuronal survival and neurological recovery after spinal cord injury (SCI). However, the critical mechanical characterization of injured spinal cord that harmonizes neuroprotective function of microglia remains poorly understood.

methodsSpinal cord tissue stiffness was assessed using atomic force microscopy (AFM) in a mouse model of crush injury. Pharmacological depletion of microglia using PLX5622 was used to explore the effect of microglia on mechanical characterization. Conditional knockout of Fascin-1 in microglia (Fascin-1 CKO) alone or in combination with inhibition of myosin activity was performed to delve into relevant mechanisms of microglia regulating mechanical signal. Immunofluorescence staining was performed to evaluate the related protein levels, inflammatory cells, and neuron survival after SCI. The Basso mouse scale score was calculated to assess functional recovery.

resultsSpinal cord tissue significantly softens after SCI. Microglia depletion or Fascin-1 knockout in microglia limits tissue softening and alters mechanical characterization, which leads to increased tissue pathology and impaired functional recovery. Mechanistically, Fascin-1 inhibits myosin activation to promote microglial migration and control mechanical characterization after SCI.

conclusionsWe reveal that Fascin-1 limits myosin activity to regulate mechanical characterization after SCI, and this mechanical signal should be considered in future approaches for the treatment of CNS diseases.

Indexed as

Microfilament ProteinsMicrogliaSpinal Cord InjuriesAnimalsCarrier ProteinsGliosisMiceReceptors, OdorantSpinal CordCarrier ProteinsfascinMicrofilament ProteinsOlfr73 protein, mouseReceptors, OdorantFascin-1Mechanical characterizationMicrogliaMyosinSpinal cord injury

Identifiers

PMID38600569
PMCPMC11005239
OpenAlexW4394680504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.